SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-200017
Filing Date
2022-07-22
Accepted
2022-07-22 16:02:00
Documents
16
Period of Report
2022-07-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d61456d8k.htm   iXBRL 8-K 28475
2 EX-1.1 d61456dex11.htm EX-1.1 201904
3 EX-5.1 d61456dex51.htm EX-5.1 12819
7 GRAPHIC g61456dsp47.jpg GRAPHIC 3890
8 GRAPHIC g61456dsp48.jpg GRAPHIC 2513
  Complete submission text file 0001193125-22-200017.txt   428584

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rvmd-20220719.xsd EX-101.SCH 2894
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvmd-20220719_lab.xml EX-101.LAB 17237
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvmd-20220719_pre.xml EX-101.PRE 10838
10 EXTRACTED XBRL INSTANCE DOCUMENT d61456d8k_htm.xml XML 3234
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39219 | Film No.: 221099982
SIC: 2836 Biological Products, (No Diagnostic Substances)